This contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for preventative maintenance coverage on Qiagen's EZ2 and QIAcell laboratory equipment, with a firm fixed price of $11,517.91 and a period of performance from November 19, 2024 to November 18, 2025.
Qiagen is an experienced federal contractor, having provided a range of products and services to support biomedical research, public health, law enforcement, and healthcare programs for various civilian and defense agencies. This contract appears to be a standalone purchase order and does not have a set-aside designation. Qiagen also holds multiple indefinite delivery vehicle (IDV) contracts with federal agencies to provide specialized products and services on a recurring basis.
Generated 12/3/24, 9:42 AM